Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing
Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)
DOI: 10.1128/aac.01813-25 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Roya Vahedi-Shahandashti und 4 weiteren Autor:innen. Beteiligte Einrichtung: European Confederation of Medical Mycology (ECMM) Excellence Center, Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, …. Hauptthemen laut MEDLINE: Triazoles, Voriconazole, Antifungal Agents, Nitriles. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Innsbruck, ISHAM Working Group Funding-Winter Call 2025.
Abstract (Originalsprache)
This study assessed whether voriconazole (VRC) gradient diffusion results can be extrapolated to isavuconazole (ISA) and posaconazole (PSC) in Aspergillus fumigatus and Aspergillus terreus by comparison with the Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) and cyp51A sequencing. Agreement with CLSI BMD was highest at 48 h, but remained limited for some azole-species combinations. VRC-PSC extrapolation was reliable in both species, whereas VRC-ISA extrapolation was species-dependent. Gradient diffusion underestimated resistance detection in some cyp51A -mutant isolates, highlighting the risk of false-susceptible interpretations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Confederation of Medical Mycology (ECMM) Excellence Center, Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Roya Vahedi-Shahandashti, David Eisele, Cornelia Lass-Flörl
Förderung
- Medical University of Innsbruck
- ISHAM Working Group Funding-Winter Call 2025
Zitieren
APA
Vahedi-Shahandashti, R., Nickel, A. S., Eisele, D., Lass-Flörl, C., & ISHAM Working Group Member of Intrinsic Antifungal Resistance (2026). Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.01813-25
Vancouver
Vahedi-Shahandashti R, Nickel AS, Eisele D, Lass-Flörl C, ISHAM Working Group Member of Intrinsic Antifungal Resistance. Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.01813-25
BibTeX
@article{VahediShahandashti2026,
author = {Vahedi-Shahandashti, Roya and Nickel, Anna-Sophia and Eisele, David and Lass-Flörl, Cornelia and ISHAM Working Group Member of Intrinsic Antifungal Resistance, ISHAM Working Group Member of Intrinsic Antifungal Resistance},
title = {Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {6},
doi = {10.1128/aac.01813-25}
}
EUVIMED